Table 6.
BP and number of antihypertensive drugs prescribed at baseline, 12 and 24 months for participants who restarted antihypertensive medications during TDR, FR or WLM and for all participants
| Number of antihypertensive drugs prescribed at baseline | Participants who had to recommence antihypertensive medications (n = 46) |
All (n = 143) |
||||
|---|---|---|---|---|---|---|
| Baseline | Year 1 | Year 2 | Baseline | Year 1 | Year 2 | |
| 0 | 0 | 16 (34.8) | 2 (4.3) | 65 (45.5) | 97 (67.8) | 81 (56.6) |
| 1 | 15 (32.6) | 16 (34.8) | 24 (52.2) | 34 (23.8) | 29 (20.3) | 37 (25.9) |
| 2 | 17 (37.0) | 11 (23.9) | 11 (23.9) | 28 (19.6) | 14 (9.8) | 16 (11.2) |
| 3 | 8 (17.4) | 3 (6.5) | 8 (17.4) | 10 (7.0) | 3 (2.1) | 8 (5.6) |
| 4 | 6 (13.0) | 0 | 1 (2.2) | 6 (4.2) | 0 (0) | 1 (0.7) |
| BP (mm/Hg) | (n = 46) | (n = 41) | (n = 36) | (n = 143) | (n = 127) | (n = 112) |
| Systolic | 138.8 ± 19.8 | 141.8 ± 13.0 | 136.7 ± 12.9 | 132.9 ± 7.5 | 133.1 ± 16.4 | 130.3 ± 13.6 |
| Diastolic | 86.6 ± 9.3 | 87.2 ± 10.4 | 85.7 ± 7.0 | 84.5 ± 10.1 | 83.6 ± 9.5 | 81.6 ± 8.5 |
Data presented as mean ± SD or n (%)